Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis

Neurokinin-1 receptor antagonists (NK-1RAs) are widely used for chemotherapy-induced nausea and vomiting (CINV) control in patients with highly emetogenic chemotherapy (HEC) and/or moderately emetogenic chemotherapy (MEC). Whether the efficacy and toxicity of antiemesis are different among various N...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2017-02, Vol.109 (2), p.djw217
Hauptverfasser:	Zhang, Yaxiong, Yang, Yunpeng, Zhang, Zhonghan, Fang, Wenfeng, Kang, Shiyang, Luo, Youli, Sheng, Jin, Zhan, Jianhua, Hong, Shaodong, Huang, Yan, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiemetics - adverse effects Antiemetics - therapeutic use Antineoplastic Agents - adverse effects Dexamethasone - therapeutic use Drug Therapy, Combination - adverse effects Humans Isoquinolines - therapeutic use Morpholines - therapeutic use Nausea - chemically induced Nausea - prevention & control Network Meta-Analysis Neurokinin-1 Receptor Antagonists - adverse effects Neurokinin-1 Receptor Antagonists - therapeutic use Quinuclidines - therapeutic use Serotonin Antagonists - therapeutic use Vomiting - chemically induced Vomiting - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!